...
search icon
dsnky-img

Daiichi Sankyo Co Ltd ADR, Common Stock

DSNKY

PNK

$24.17

+$0.28

(1.17%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$44.55B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
22.4811
Volume info-icon
This is the total number of shares traded during the most recent trading day.
131.34K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
1.69%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.26
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$21.34 L
$39.87 H
$24.17

About Daiichi Sankyo Co Ltd ADR, Common Stock

Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally. The company offers Enhertu to treat patients with HER2 positive and low breast cancer, HER2 positive gastric or gastroesophageal junction adenocarcinoma, and HER2 positive solid tumors; Turalio, an oral small molecule that targets colony stimulating factor 1 receptor, KIT proto-oncogene receptor tyrosine kinase, and FMS-like tyrosine kinase 3 harboring an internal tandem duplication mutation; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with acute myeloid leukemia; Injectafer, a ferric carboxymaltose injection to treat iron deficiency; and DATROWAY to treat adult patients with hormone receptor (HR) positive, and HER2 negative. It also provides Liziana and Savaysa, direct factor Xa inhibitors; Minnebro, Olmetec, Olmetec Plus, Rezaltas, Sevikar, and Sevikar HCT antihypertensive agents; Nilemdo, an oral treatment which lowers cholesterol; Nustendi, a fixed-dose combination tablet of bempedoic acid and ezetimibe to reduce cholesterol; and Efient, an anti-platelet agent. In addition, the company offers Canalia and Tenelia for the treatment of type 2 diabetes mellitus; Emgalty and Reyvow to treat migraine attacks; Pralia for the treatment of osteoporosis/inhibitor of the progression of bone erosion associated with rheumatoid arthritis; Ranmark to treat bone complications caused by bone metastasis from tumors; Tarlige for treating neuropathic pain; Venofer for the treatment of iron deficiency anemia; and Vimpat, an anti-seizure medication. Further, it provides vaccines for COVID-19 infection, influenza infection, adsorbed cell culture-derived influenza (H5N1), measles/rubella infection, and mumps. Daiichi Sankyo Company, Limited was founded in 1899 and is headquartered in Tokyo, Japan. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameDSNKYSectorS&P500
1-Week Return-2.77%0.37%-0.73%
1-Month Return-3.07%3.42%1.48%
3-Month Return-10.92%3.65%8.04%
6-Month Return-2.3%-8.04%9.65%
1-Year Return-42.32%-12.33%15.99%
3-Year Return-19.18%10.06%63.33%
5-Year Return-20.1%25.69%79.08%
10-Year Return293.25%96.37%228.67%

Financials

Mar '21Mar '22Mar '23Mar '24Mar '255YR TREND
Total Revenue962.52B1.04T1.28T1.60T1.89T[{"date":"2021-03-31","value":51.03,"profit":true},{"date":"2022-03-31","value":55.4,"profit":true},{"date":"2023-03-31","value":67.78,"profit":true},{"date":"2024-03-31","value":84.91,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Cost of Revenue338.29B353.33B363.52B415.32B415.80B[{"date":"2021-03-31","value":81.36,"profit":true},{"date":"2022-03-31","value":84.98,"profit":true},{"date":"2023-03-31","value":87.43,"profit":true},{"date":"2024-03-31","value":99.89,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Gross Profit624.23B691.56B914.95B1.19T1.47T[{"date":"2021-03-31","value":42.45,"profit":true},{"date":"2022-03-31","value":47.03,"profit":true},{"date":"2023-03-31","value":62.22,"profit":true},{"date":"2024-03-31","value":80.68,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Gross Margin64.85%66.19%71.57%74.07%77.96%[{"date":"2021-03-31","value":83.19,"profit":true},{"date":"2022-03-31","value":84.9,"profit":true},{"date":"2023-03-31","value":91.8,"profit":true},{"date":"2024-03-31","value":95.01,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Operating Expenses560.43B618.54B794.37B974.78B1.14T[{"date":"2021-03-31","value":49.22,"profit":true},{"date":"2022-03-31","value":54.33,"profit":true},{"date":"2023-03-31","value":69.77,"profit":true},{"date":"2024-03-31","value":85.62,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Operating Income63.80B73.03B120.58B211.59B331.93B[{"date":"2021-03-31","value":19.22,"profit":true},{"date":"2022-03-31","value":22,"profit":true},{"date":"2023-03-31","value":36.33,"profit":true},{"date":"2024-03-31","value":63.75,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Total Non-Operating Income/Expense20.49B851.00M12.57B51.11B45.95B[{"date":"2021-03-31","value":40.09,"profit":true},{"date":"2022-03-31","value":1.67,"profit":true},{"date":"2023-03-31","value":24.59,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":89.92,"profit":true}]
Pre-Tax Income74.12B73.52B126.85B237.23B355.63B[{"date":"2021-03-31","value":20.84,"profit":true},{"date":"2022-03-31","value":20.67,"profit":true},{"date":"2023-03-31","value":35.67,"profit":true},{"date":"2024-03-31","value":66.71,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Income Taxes(1.71B)6.54B17.67B36.22B59.87B[{"date":"2021-03-31","value":-2.85,"profit":false},{"date":"2022-03-31","value":10.93,"profit":true},{"date":"2023-03-31","value":29.51,"profit":true},{"date":"2024-03-31","value":60.49,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Income After Taxes75.83B66.97B109.19B201.02B295.76B[{"date":"2021-03-31","value":25.64,"profit":true},{"date":"2022-03-31","value":22.64,"profit":true},{"date":"2023-03-31","value":36.92,"profit":true},{"date":"2024-03-31","value":67.97,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Income From Continuous Operations75.83B66.97B109.19B201.02B295.76B[{"date":"2021-03-31","value":25.64,"profit":true},{"date":"2022-03-31","value":22.64,"profit":true},{"date":"2023-03-31","value":36.92,"profit":true},{"date":"2024-03-31","value":67.97,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Net Income75.96B66.97B109.19B200.73B295.76B[{"date":"2021-03-31","value":25.68,"profit":true},{"date":"2022-03-31","value":22.64,"profit":true},{"date":"2023-03-31","value":36.92,"profit":true},{"date":"2024-03-31","value":67.87,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
EPS (Diluted)16.670.280.420.7347.11[{"date":"2021-03-31","value":35.38,"profit":true},{"date":"2022-03-31","value":0.59,"profit":true},{"date":"2023-03-31","value":0.89,"profit":true},{"date":"2024-03-31","value":1.54,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

DSNKY
Cash Ratio 0.96
Current Ratio 2.53
Quick Ratio 1.85

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

DSNKY
ROA (LTM) 6.08%
ROE (LTM) 17.93%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

DSNKY
Debt Ratio Lower is generally better. Negative is bad. 0.53
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.47

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

DSNKY
Trailing PE 22.48
Forward PE 21.28
P/S (TTM) 0.02
P/B 4.14
Price/FCF 1
EV/R 3.25
EV/Ebitda 14.05
PEG 7.71

FAQs

What is Daiichi Sankyo Co Ltd ADR share price today?

Daiichi Sankyo Co Ltd ADR (DSNKY) share price today is $24.17

Can Indians buy Daiichi Sankyo Co Ltd ADR shares?

Yes, Indians can buy shares of Daiichi Sankyo Co Ltd ADR (DSNKY) on Vested. To buy Daiichi Sankyo Co Ltd ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DSNKY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Daiichi Sankyo Co Ltd ADR be purchased?

Yes, you can purchase fractional shares of Daiichi Sankyo Co Ltd ADR (DSNKY) via the Vested app. You can start investing in Daiichi Sankyo Co Ltd ADR (DSNKY) with a minimum investment of $1.

How to invest in Daiichi Sankyo Co Ltd ADR shares from India?

You can invest in shares of Daiichi Sankyo Co Ltd ADR (DSNKY) via Vested in three simple steps:

  • Click on Sign Up or Invest in DSNKY stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Daiichi Sankyo Co Ltd ADR shares
What is Daiichi Sankyo Co Ltd ADR 52-week high and low stock price?

The 52-week high price of Daiichi Sankyo Co Ltd ADR (DSNKY) is $39.87. The 52-week low price of Daiichi Sankyo Co Ltd ADR (DSNKY) is $21.34.

What is Daiichi Sankyo Co Ltd ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Daiichi Sankyo Co Ltd ADR (DSNKY) is 22.4811

What is Daiichi Sankyo Co Ltd ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Daiichi Sankyo Co Ltd ADR (DSNKY) is 4.14

What is Daiichi Sankyo Co Ltd ADR dividend yield?

The dividend yield of Daiichi Sankyo Co Ltd ADR (DSNKY) is 1.69%

What is the Market Cap of Daiichi Sankyo Co Ltd ADR?

The market capitalization of Daiichi Sankyo Co Ltd ADR (DSNKY) is $44.55B

What is Daiichi Sankyo Co Ltd ADR’s stock symbol?

The stock symbol (or ticker) of Daiichi Sankyo Co Ltd ADR is DSNKY

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top